Chemotherapy Combined With Apatinib and PD-1 Antibody
Clinical trial NCT05025033 · COMPLETED
Trial details
- NCT number
- NCT05025033
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2022-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.